All media enquiries should be directed to: Carol Moore of Moore PR T: (02) 9560 2826 M: 0402 382 363 E:

This page displays recent media items. For older media items, please visit the media archive.

6 March 2018 Stealth BioTherapeutics’ clinical trial for Barth syndrome treatment
Media release about Stealth BioTherapeutics’ TAZPOWER clinical trial in the USA, a study evaluating elamipretide as treatment for patients with genetically confirmed Barth syndrome.

1 March 2018 REATA’s clinical trial for mitochondrial mypothy treatment
Media release on findings from biopharmaceutical company REATA’s clinical trial on treatment (maveloxolone) for patients with mitochondrial myopathies.

27 February 2018 Victorian Clinical Genetics Services and Edico Genome Deploy First DRAGEN Bio-IT Platform in Australia
The Murdoch Children’s Research Institute’s (MCRI) Victorian Clinical Genetics Services (VCGS) has partnered with Edico Genome, the developer of DNA data processor DRAGEN, to reduce the turnaround time of genomic testing results in Australia from months to days.

2 February 2018 Mitochondrial donation in the UK
Media release from British newspaper, The Guardian, about a fertility clinic in the UK being granted permission to perform mitochondrial donation for two women with MERRF syndrome.

27 November 2017 Khondrion’s phase II clinical trial results
Media release from Dutch pharmaceutical company, Khondrion, detailing the preliminary results of their phase II KHENERGY study.

5 September 2017 AMDF’s Global Mitochondrial Disease Awareness Week initiatives
Media release on AMDF’s Awareness Week 2017 events, including Light Up for Mito and Stay in Bed Day.

7 August 2017 Research into mitochondrial disease diagnosis
Media release on a new genetic testing approach that could improve diagnosis for mitochondrial disease.

25 July 2017 AMDF statement on the plight of baby Charlie Gard
A statement from AMDF CEO Sean Murray regarding the need for more research funding in the wake of baby Charlie’s plight.

23 June 2017 AMDF’s response to Senator Hanson’s comments
AMDF’s response to Senator Pauline Hanson’s comments regarding the education of children with disabilities.

1 June 2017 INSPIRE article on genomic sequencing
Research Australia’s INSPIRE magazine article that discusses why pursuing a diagnosis of mitochondrial disease is important, and how genomic sequencing can improve diagnoses in Australia.

24 May 2017 RCPA article on the AMDF-AGHA partnership
Royal College of Pathologists of Australasia monthly newsletter article that discusses AMDF’s partnership with the Australian Genomic Health Alliance, and how the project this project will enable every person with a strong suspicion of mito to gain a definitive diagnosis via genetic testing.

17 March 2017 First clinical mitochondrial donation licence granted in UK
AMDF media release regarding the first clinical mitochondrial donation licence in the UK. AMDF applauds the announcement as a major step forward for the global mitochondrial disease community.

16 January 2017 story on the Beard family
A story about Pippa and Tony Beard. The Beard family have a history of mito, with Pippa being severely affected. Pippa’s sister Toby experiences mild symptoms and would love have a child of her own. Mitochondrial donation could ensure that she doesn’t pass on this debilitating disease to her future child.


AMDF media release regarding the latest updates from the Human Fertilisation and Embryology Authority (HFEA). The HFEA have officially authorised the use of mitochondrial donation in the UK. AMDF hopes that the Australian government will follow suit and legalise the IVF technique.